CHEST 2026
-
Meet the 2026 CHEST Network Rising Stars
Hear from the seven early career clinicians who were named CHEST Network Rising Stars, honoring their growth within CHEST as well as contributions in clinical care, education, research, or other scholarly activity.
-
Session to focus on tobacco cessation counseling for youth, young adults
Presenters will review the latest research and clinical case studies to better equip clinicians in tailoring effective cessation strategies for youth and young adults, said Frank Leone, MD, MS, FCCP.
-
Panel to delve into matching patients with the best CSA device therapy
In central sleep apnea (CSA) care, clinicians are increasingly asked to move beyond one-size-fits-all approaches and toward phenotype-driven, patient-centered care, said Timothy I. Morgenthaler, MD, FCCP.
-
Experts to tackle evolving therapeutic options for ILD
The treatment landscape for interstitial lung diseases (ILDs) has expanded dramatically in recent years, creating new opportunities—and new challenges—for clinicians, said Sean J. Callahan, MD, FCCP.
-
Celebrate the contributions of dedicated CHEST members
CHEST will recognize members who are making an impact in education, research, clinical practice, and CHEST as an organization during the Opening Session on Sunday, October 18.
-
25 years of CHEST Challenge: Catching up with former finalists
Ahead of the 25th annual CHEST Challenge Championship in Phoenix, finalists from different eras share their memories from participating and the lasting impact it had on their careers.
-
Session to explore how biologics and antialarmins are changing the COPD landscape
Biologics and antialarmins are rewriting the playbook for COPD treatment and opening the field to more targeted therapies and precision medicine, said Sara Assaf, MD.
-
Experts to highlight pneumothorax best practices, real-world troubleshooting
The session will guide attendees through complex pneumothorax decision-making and explore cases from the audience, said Laura Kathleen Frye, MD, FCCP.
-
Chest infections and disaster response at CHEST 2026: Updates on community-acquired pneumonia and more
Other major topics of discussion will include endemic infections, rare-but-deadly pulmonary pathogens, and changes in vaccine policy, said Ryan Maves, MD, FCCP.
-
Sleep medicine at CHEST 2026: Fresh look at GLP-1 drugs for OSA
Sessions will look at new information about patients who are receiving glucagon-like peptide-1 (GLP-1) medications and how that affects their sleep-disordered breathing, said Sherri Katz, MD, FCCP.
